States announce $26B proposed settlement with opioid maker/distributors
State attorneys general yesterday announced a $26 billion proposed settlement with Johnson & Johnson and distributors McKesson, Cardinal Health and Amerisource Bergen over the companies’ alleged role in creating and fueling the opioid epidemic. A number of states have signed the agreement, which still must be signed by other state and local governments involved in the litigation. They said most of the settlement would go to opioid treatment and prevention, with each state’s share based on a formula that takes into account factors such as the number of overdose deaths, opioids prescribed and residents with substance use disorder.
Related News Articles
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Headline
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…